No person shall administer or cause to be administered to a horse within 48 hours of a race in which it is scheduled to run any medication (except as permitted by part 7890.0100, subpart 13a, items A to D) by injection, oral or topical administration, rectal infusion or suppository, or by inhalation and no horse participating in a race shall carry in its body any substance foreign to the natural horse, except as permitted by subparts 7, item C, 7a, 9, and 10 and part 7890.0100, subpart 13a, items A to D. Post-race samples of plasma, serum, hair, or urine must not contain any substances, drugs, medications, or metabolites of substances, drugs, or medications not specifically permitted by commission rule or law.
The use of a nasogastric tube for the administration of any substance to an entered horse within the 48-hour period prior to post time shall not be permitted without prior permission of the commission veterinarian. No licensee other than a veterinarian shall possess a nasogastric tube on the grounds of an association under the jurisdiction of the commission. For purposes of this subpart, "nasogastric tube" means any hose or tube more than 12 inches in length and more than one-quarter inch in diameter.
The use of extracorporeal shock wave therapy or radial pulse wave therapy shall not be permitted unless the following conditions are met:
any treated horse shall be placed on the veterinarian's list and not be permitted to have a timed workout or race for a minimum of 30 days following treatment with day one being the first day of treatment;
the use of extracorporeal shock wave therapy or radial pulse wave therapy machines shall be limited to veterinarians licensed by the commission and must be performed in a central location at the licensed racetrack determined by the commission veterinarian during hours specified by the commission veterinarian;
any extracorporeal shock wave therapy or radial pulse wave therapy machines on association grounds must be registered with the commission veterinarian prior to use; and
all extracorporeal shock wave therapy or radial pulse wave therapy treatments must be recorded on a form prescribed by the commission, and provided to the commission veterinarian 24 hours prior to treatment.
The possession or use of blood doping agents by any person, including but not limited to the following blood doping agents, on the premises of a facility under the jurisdiction of the commission is forbidden:
The use of all NSAIDs shall be discontinued at least 48 hours before the post time for the race in which the horse is entered. The use of any intra-articular corticosteroid shall be discontinued at least seven days before post time for the race in which the horse is entered. The presence of only one corticosteroid is permitted in a post-race sample.
The possession or use of a drug, substance, venom, medication, or blood doping agent for which a recognized analytical method to detect and confirm the administration of such substance has not been developed on the premises of a facility under the jurisdiction of the commission is prohibited.
The use of agents that elevate the horse's bicarbonate level, TCO2, or pH level above those existing naturally in the untreated horse at normal physiological concentrations is prohibited. The following also apply to TCO2:
A commission veterinarian may draw whole blood, serum, or plasma samples from a horse for the purpose of obtaining a TCO2 level.
Blood samples for TCO2 may be drawn prior to or after the race. Samples drawn prior to a race shall be drawn before the official post time. For the purpose of harness racing, blood samples shall be drawn prior to warm-up. Samples drawn after the race shall be drawn no sooner than 90 minutes following official post time for that race.
The pre-race or post-race TCO2 level in the blood shall not exceed 37 millimoles per liter of blood.
The provisions of part 7892.0120, subpart 5, pertaining to split samples, shall not apply to blood samples drawn for the purpose of TCO2 testing.
Provisions for split sample testing for TCO2 analysis shall be arranged by the trainer or designee at the time of sampling. The trainer shall be responsible for the cost of split sample testing. The trainer or designee shall make arrangements for payment prior to or at the time of sampling. The split sample shall be sent to the commission contract laboratory as a separate blind sample. No other provisions for split sample testing shall be available.
No Androgenic-anabolic steroids (AAS) shall be permitted in test samples collected from racing horses except for endogenous concentrations of nandrolone and naturally occurring substances boldenone and testosterone at concentrations less than the indicated thresholds. Concentrations of these AAS shall not exceed the following plasma or serum thresholds for free (i.e. not conjugated) substance or urine threshold concentrations for total (i.e., free drug or metabolite and drug or metabolite liberated from its conjugates):
Boldenone - 15 ng/ml of total boldenone in urine of male horses other than geldings; 1 ng/ml in fillies, mares, and geldings; or not greater than 25 pg/ml of boldenone in plasma or serum of all horses regardless of sex.
in geldings - 1 ng/ml total nandrolone in urine or not greater than 25 pg/ml of nandrolone in plasma or serum;
in fillies and mares - 1 ng/ml total nandrolone in urine or not greater than 25 pg/ml of nandrolone in plasma or serum; and
in male horses other than geldings - 45 ng/ml of metabolite (5α-oestrane-3β, 17α-diol in urine).
in geldings - 20 ng/ml total testosterone in urine or 100 pg/ml of testosterone in plasma or serum;
in fillies and mares - 55 ng/ml total testosterone in urine or 100 pg/ml of testosterone in plasma or serum;
in fillies and mares that are confirmed at the time of racing as being pregnant, testosterone is not regulated; and
in male horses other than geldings 2,000 pg/ml of plasma or serum.
All other AAS are prohibited in racing horses.
The sex of all horses shall be identified on all samples sent to the laboratory. Any horse to which one of these AAS has been administered in order to assist in the recovery from an illness or injury may be placed on the veterinarian's list in order to monitor the concentration of the drug or metabolite in urine. After the concentration has fallen below the designated threshold for the administered AAS, the horse is eligible to be removed from the list.
The use of a thyroid supplement is limited to a hypothyroid horse diagnosed with a thyrotropin releasing hormone (TRH) stimulation test.
Results of the TRH test must be submitted to the commission veterinarian and approved prior to the horse receiving a thyroid supplement.
If a horse is currently receiving a thyroid supplement, TRH test results must be provided to the commission veterinarian or thyroid supplement administration discontinued and TRH testing completed after a 30-day washout period.
Clenbuterol use is prohibited in the racing and training of a Quarter Horse and only permitted in the racing and training of other breeds if the following conditions are met:
Clenbuterol is prescribed by a licensed veterinarian for a specifically named horse, stating the diagnosis, the recommended dosage levels, and the duration of clenbuterol treatment, not to exceed 30 days. The required information must be submitted to the commission veterinarian on a form and by a deadline established by the commission.
Trainers must notify a commission veterinarian daily of all horses in their custody having been administered clenbuterol. Notification shall be made on a form and by a deadline established by the commission.
A horse administered clenbuterol shall be placed on the official veterinarian's list and remains on the list until all conditions for removal have been met including an official timed workout with reports of negative clenbuterol blood and urine sampling.
A horse may not be entered to race until the horse has completed all requirements in item C.
The possession or use of anabolic androgenic steroids other than as provided in subpart 7a, naturally occurring venoms, derivatives of venoms, synthetic analogues of venoms, derivatives of synthetic analogues of venoms, growth hormone, blood doping agents, or any substance that enhances the oxygenation of equine tissue by any person on the premises of any licensed facility under the jurisdiction of the commission is not permitted.
For Thoroughbreds and Quarter Horses, the use of any intra-articular injection within 14 days of the race in which the horse is entered is prohibited.
For Standardbreds, the use of any intra-articular injection within seven days of the race in which the horse is entered is prohibited.
No endogenous, dietary, or environmental substances shall be allowed in the test sample of a horse except as provided in the Racing Commissioners International Endogenous, Dietary, or Environmental Substances Schedule, which is incorporated by reference.
No medications other than those specifically permitted under this chapter shall be allowed in the post-race or out-of-competition test sample of a horse. Serum or urine thresholds on permitted controlled therapeutic medications shall not exceed those found in the Association of Racing Commissioners International Controlled Therapeutic Medication Schedule for Horses, which is incorporated by reference.
No person on association grounds where horses are lodged or kept, excluding licensed veterinarians, shall have in or upon association grounds which that person occupies or has the right to occupy, or in that person's personal property or effects or vehicle in that person's care, custody, or control, a drug, medication, chemical, foreign substance, or other substance that is prohibited in a horse on a race day unless the product is labeled in accordance with this subpart.
Any drug or medication that is used or kept on association grounds and that, by federal or state law, requires a prescription must have been validly prescribed by a duly licensed veterinarian, and in compliance with the applicable state statutes. All allowable medications must be labeled in accordance with state and federal laws and shall have a prescription label that is securely attached and clearly ascribed to show the following:
the prescription number that is recorded by the dispensing veterinarian or pharmacist and kept in the animal's medical record;
the date the prescription was dispensed;
the name, address, and telephone number of the company manufacturing the medication;
the lot number and expiration date of the medication;
the name, address, and telephone number of the veterinarian prescribing or dispensing the medication;
the name of each patient (horse) for whom the medication is prescribed or dispensed;
the name of the person (trainer) to whom the medication was dispensed;
the name, active ingredient, and quantity of the medication prescribed;
the dose, dosage, route of administration, and duration of treatment; and
cautionary statements as needed.
Possession of an expired prescription medication is considered a violation of the rule.
Veterinary drugs shall be compounded in accordance with all applicable state and federal laws. Compounded medication shall be dispensed only by a prescription issued by a licensed veterinarian to meet the medical needs of a specific horse and for use only in that specific horse.
Possession of an improperly labeled medication by a veterinarian, trainer, groom, or any other licensee is considered a violation.
No electrical, mechanical, or battery-powered device or machine may be used to administer therapy or treatment to a horse within 48 hours of the time the horse is scheduled to race, unless approved in advance by the stewards in consultation with the commission veterinarian.
9 SR 2527; 10 SR 1908; 11 SR 2201; 12 SR 2393; 31 SR 1277; 33 SR 8; 34 SR 83; 35 SR 375; 35 SR 627; 36 SR 1407; 39 SR 1739; 40 SR 1393; 41 SR 1322; 42 SR 1258; 44 SR 1047; 46 SR 6; 46 SR 1210
May 12, 2022
Official Publication of the State of Minnesota
Revisor of Statutes